Hyperspectral imaging associates reflectance spectra with each pixel of the image and treats the signal received in various wavelengths.
As technology quickly evolves, there are numerous X-ray modalities using different tools in the attempt to best image and treat efficiently these diseases, disorders or other related clinical conditions.
Pretargeting is also one way to use short-lived radionuclides to image and treat cancers that do not over-express receptors or enzymes that could be targeted with small peptides or inhibitors.
It looks for 'features' in an image and treats the areas between them as seams or 'fill.' Stretching an image keeps the features undistorted and increases the fill, 'fattening' the seams.
The hNIS has been exploited to image and treat thyroid cancer.
These peptides may serve as useful theranostics which may be used to both image and treat breast cancer.
New leads on the development of personalized theranostic (image and treat) agents would allow for more accuracy in the selection of patients who may respond to treatment.
Resected tissues from the mice were then imaged and treated with the laser using the paired fluorescence-imaging/ laser ablation device, generating ablation clefts with sub-millimeter precision and minimal underlying tissue damage.
The brain, heart, liver, spleen, lungs, kidneys, bladder, and lumbar vertebrae were visually identified on the images and treated as source organs of radioactivity for dosimetry calculation of [18 F]AFM in monkeys.
Afterwards, the slide was imaged and treated with a 1 1 solution of tetrabutylammonium fluoride (TBAF; 1 m)/THF and DMF at 45 °C for 15 min to cleave the fluorescent dye and 3′- O- 2-cyanoethyl) grO- 2-cyanoethyl
